October 14, 2025

Do Quadruple Therapies Beat Triple for H. pylori?

Concomitant and bismuth quadruple regimens cleared ~90% of patients and outperformed triple therapy; sequential achieved ~84%. Adherence remained ~97% despite higher but manageable side effects.

Conexiant

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 29, 2025

The 7-Day Risk ACIP Didn't Address

Delaying newborn hepatitis B shots may leave infants exposed to everyday transmission risks.

KFF Health News

September 29, 2025

Genetic Study: Fat Sites May Influence Cancer

Researchers examine how body fat distribution may influence risks across 12 cancer types.

Conexiant

September 29, 2025

What If Early Cancer Rise Isn't What It Seems?

Analysis reveals stable mortality despite doubled incidence rates in patients under 50.

Conexiant

September 18, 2025

Cuts or Care: ‘What Are the Priorities?’

New residency programs launch as Northern California faces ongoing physician shortages and potential funding reductions.

KFF Health News

September 18, 2025

Oral Microbes Triple Pancreatic Cancer Risk

Largest two-cohort prospective analysis identifies 27 oral microbes that together form a potent biomarker candidate

Conexiant

September 05, 2025

Ancillary Features Don’t Improve LI-RADS Accuracy

The study raises questions about whether ancillary features still warrant inclusion in liver imaging workflows.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant